Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| ciliated cell | 17 studies | 36% ± 14% | |
| astrocyte | 8 studies | 35% ± 16% | |
| retinal pigment epithelial cell | 3 studies | 26% ± 9% | |
| ependymal cell | 3 studies | 45% ± 16% |
Insufficient scRNA-seq data for expression of NWD1 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| prostate | 93% | 1553.62 | 229 / 245 | 100% | 31.43 | 502 / 502 |
| brain | 95% | 1364.54 | 2512 / 2642 | 82% | 5.93 | 581 / 705 |
| pancreas | 61% | 115.59 | 201 / 328 | 41% | 0.95 | 73 / 178 |
| stomach | 72% | 312.70 | 260 / 359 | 15% | 0.35 | 43 / 286 |
| thymus | 64% | 207.93 | 421 / 653 | 22% | 0.64 | 133 / 605 |
| lung | 38% | 282.99 | 222 / 578 | 31% | 1.51 | 353 / 1155 |
| uterus | 8% | 78.42 | 13 / 170 | 35% | 2.03 | 159 / 459 |
| esophagus | 16% | 31.22 | 227 / 1445 | 25% | 0.81 | 46 / 183 |
| breast | 15% | 29.70 | 68 / 459 | 20% | 0.83 | 229 / 1118 |
| ovary | 2% | 3.01 | 3 / 180 | 33% | 1.33 | 144 / 430 |
| bladder | 19% | 67.76 | 4 / 21 | 13% | 0.29 | 68 / 504 |
| skin | 27% | 56.39 | 487 / 1809 | 1% | 0.02 | 4 / 472 |
| tonsil | 0% | 0 | 0 / 0 | 27% | 0.80 | 12 / 45 |
| kidney | 8% | 12.60 | 7 / 89 | 17% | 0.41 | 152 / 901 |
| intestine | 2% | 3.03 | 18 / 966 | 19% | 0.37 | 98 / 527 |
| eye | 0% | 0 | 0 / 0 | 4% | 0.06 | 3 / 80 |
| muscle | 2% | 4.59 | 18 / 803 | 0% | 0 | 0 / 0 |
| adrenal gland | 0% | 0.53 | 1 / 258 | 1% | 0.04 | 2 / 230 |
| blood vessel | 1% | 1.61 | 13 / 1335 | 0% | 0 | 0 / 0 |
| adipose | 1% | 1.93 | 11 / 1204 | 0% | 0 | 0 / 0 |
| liver | 0% | 0 | 0 / 226 | 1% | 0.01 | 3 / 406 |
| peripheral blood | 0% | 1.17 | 2 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| heart | 0% | 0 | 0 / 861 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spleen | 0% | 0 | 0 / 241 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0010628 | Biological process | positive regulation of gene expression |
| GO_0032088 | Biological process | negative regulation of NF-kappaB transcription factor activity |
| GO_0005730 | Cellular component | nucleolus |
| GO_0005829 | Cellular component | cytosol |
| GO_0005524 | Molecular function | ATP binding |
| Gene name | NWD1 |
| Protein name | NACHT and WD repeat domain containing 1 NACHT domain- and WD repeat-containing protein 1 |
| Synonyms | |
| Description | FUNCTION: May play a role in the control of androgen receptor (AR) protein steady-state levels. . |
| Accessions | ENST00000518676.5 F8W0U9 ENST00000673803.1 [Q149M9-3] E5RJJ1 ENST00000673758.1 A0A669KAX7 ENST00000524140.7 [Q149M9-3] ENST00000438489.6 [Q149M9-2] ENST00000674103.1 A0A669KB99 ENST00000552788.1 [Q149M9-1] ENST00000549814.5 Q149M9 ENST00000646016.2 [Q149M9-2] |